Germany
Japan
United Kingdom
China
Anti-ERBB2 / HER2 / CD340 Reference Antibody (margetuximab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Primary Antibodies
View as table DownloadAnti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab deruxtecan)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Dxd |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (pertuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (trastuzumab-MMAE)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | MMAE |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Mouse, Rat, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (zanidatamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Trastuzumab duocarmazine)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (timigutuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (disitamab vedotin)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | MMAE |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (gancotamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Anbenitamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (BioMab patent anti-Her2)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (coprelotamab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human, Cynomolgus |
| Conjugation | Unconjugated |
Anti-ERBB2 / HER2 / CD340 Reference Antibody (Hersintuzumab)
| Applications | Animal Model, ELISA, FACS, FN, Kinetics |
| Reactivities | Human |
| Conjugation | Unconjugated |
Active filters
Target Symbol
- ERBB2 / HER2 / CD340
Reactivities
- Human
Applications
- ELISA